V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005542 | 310002576 | 1.77 | null | null | 2016-02-18 | 2016-02-20 | LEAM | N | N | 310023689 | CARBOPLATIN + RT |
| 310005543 | 310002577 | 1.78 | 134 | Curative (C) | 2014-10-08 | 2014-10-12 | DA 3 + 10 | 02 | N | 310023699 | DABRAFENIB + TRAMETINIB |
| 310005544 | 310002578 | 0 | 69 | Curative (C) | 2018-08-13 | 2018-06-04 | CARBOPLATIN + RT | 02 | N | 310023712 | BEP |
| 310005545 | 310007067 | 1.62 | null | Neo-adjuvant (N) | 2015-05-29 | 2015-06-06 | CYCLOPHOSPHAMIDE + MESNA | N | N | 310023713 | CISPLATIN + FLUOROURACIL + RT |
| 310005546 | 310002579 | null | 41.8 | null | 2015-08-13 | 2015-08-13 | VINCRISTINE | N | null | 310023716 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005547 | 310002579 | 0 | 76.2 | Neo-adjuvant (N) | 2013-01-23 | 2013-02-12 | GDP | N | N | 310023716 | BEP |
| 310005548 | 310002580 | 1.8 | null | Palliative (P) | 2015-07-17 | 2015-07-17 | IVE | N | N | 310023725 | OCTREOTIDE |
| 310005549 | 310002581 | 1.48 | 99.8 | Palliative (P) | 2016-10-24 | 2016-10-24 | CETUXIMAB | Y | N | 310023810 | CVP R |
| 310005550 | 310002582 | null | 94.6 | Palliative (P) | 2016-10-09 | 2016-10-23 | CARBOPLATIN + VINORELBINE | N | N | 310023826 | CAPECITABINE + CISPLATIN + RT |
| 310005551 | 310002582 | null | 37.8 | Curative (C) | 2016-12-17 | 2017-01-07 | Docetaxel | N | N | 310023826 | MEDROXYPROGESTERONE |
| 310005552 | 310009292 | null | null | Palliative (P) | 2017-01-29 | 2017-02-10 | Cisplatin + Fluorouracil + RT 5day | 2 | N | 310023870 | CARBO + FLUOROURACIL |
| 310005553 | 310002583 | 1.52 | 65 | Neo-adjuvant (N) | 2017-02-23 | 2017-02-25 | CAPECITABINE + TEMOZOLOMIDE | N | N | 310023918 | SUNITINIB |
| 310005554 | 310007070 | 1.63 | 49 | Curative (C) | 2014-05-29 | 2014-06-12 | ICON8B TRIAL | 02 | N | 310023950 | RUXOLITINIB |
| 310005555 | 310002584 | null | 68 | Disease modification (D) | 2018-02-09 | 2018-02-11 | Methotrexate High Dose (3g/m2) | 2 | N | 310023951 | CAPECITABINE + CARBOPLATIN |
| 310005556 | 310002585 | 1.62 | 89.5 | Palliative (P) | 2016-01-24 | 2016-02-07 | RCEOP | N | N | 310023973 | ESHAP |
| 310005557 | 310002586 | null | null | Palliative (P) | null | 2013-12-29 | IVE | null | null | 310023978 | CARBO + ETOPOSIDE + VINCRISTINE |
| 310005558 | 310007071 | 1.68 | 86.6 | Palliative (P) | 2017-04-21 | 2017-05-03 | BEP 5 Day | N | N | 310023987 | POUT TRIAL |
| 310005559 | 310002587 | 1.75 | 108 | Disease modification (D) | 2017-05-09 | 2017-05-16 | Cyclophosphamide High Dose | N | N | 310024021 | CVP R |
| 310005560 | 310002587 | 1.71 | null | Palliative (P) | 2015-07-02 | 2015-07-03 | Sunitinib | 02 | N | 310024021 | POUT TRIAL |
| 310005561 | 310002587 | 1.54 | null | Adjuvant (A) | 2017-08-14 | 2017-08-15 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 310024021 | SUNITINIB |
| 310005562 | 310002588 | 1.64 | 92 | Curative (C) | 2016-06-27 | 2016-06-29 | Gemcitabine + Capecitabine | N | N | 310024083 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 310005563 | 310002588 | 1.66 | 64 | Palliative (P) | 2016-06-07 | 2016-06-12 | Pazopanib | 02 | null | 310024083 | LENALIDOMIDE |
| 310005564 | 310002589 | 1.73 | 78.4 | Curative (C) | 2017-11-03 | 2017-11-03 | Bevacizumab 7.5mg/kg | 2 | N | 310024116 | DHAP |
| 310005565 | 310002590 | 1.67 | 106 | Disease modification (D) | 2017-01-05 | 2017-01-05 | IVE | 02 | N | 310024133 | CHLORAMBUCIL |
| 310005566 | 310002590 | 1.68 | 54 | Palliative (P) | 2017-06-02 | 2017-06-11 | R-CHOEP | 02 | N | 310024133 | DABRAFENIB |
| 310005567 | 310009294 | 1.63 | null | Curative (C) | 2018-11-09 | 2018-11-23 | CARBOPLATIN + PACLITAXEL + RT | N | N | 310024200 | CYCLOPHOSPHAMIDE |
| 310005568 | 310009294 | 1.73 | null | Curative (C) | 2015-05-18 | 2015-06-05 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | N | N | 310024200 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 310005569 | 310002591 | 1.6 | null | Palliative (P) | 2016-06-28 | 2016-07-13 | BEVACIZUMAB + CARBO | 02 | null | 310024213 | R-EPOCH |
| 310005570 | 310002591 | null | 68 | Curative (C) | 1971-08-04 | 2015-12-30 | IVA | N | N | 310024213 | FEC |
| 310005571 | 310009295 | null | 54 | Palliative (P) | 2017-12-28 | 2017-12-28 | Azacitidine | N | N | 310024263 | EPIRUBICIN |
| 310005572 | 310002592 | 1.73 | 76.6 | Curative (C) | null | 2017-09-16 | Mitoxantrone | 2 | N | 310024286 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 310005573 | 310002593 | 1.69 | 72.4 | Palliative (P) | 2016-01-23 | 2016-01-23 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | N | 310024307 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005574 | 310002594 | 0 | 76.3 | Curative (C) | 2018-02-13 | 2018-02-20 | Bevacizumab 7.5mg/kg | N | N | 310024335 | BORTEZOMIB |
| 310005575 | 310007076 | null | 0 | Curative (C) | 2014-03-20 | 2014-03-24 | ALL UKALL2011 Ind B Sht Dex (PAsp) | null | N | 310024340 | DOCETAXEL |
| 310005576 | 310002595 | 1.72 | null | Palliative (P) | 2016-11-04 | 2016-11-06 | Bevacizumab 7.5mg/kg | N | N | 310024360 | AZACITIDINE |
| 310005577 | 310007077 | 1.76 | null | Not known (9) | 2019-01-10 | 2019-01-18 | CARBOPLATIN + VINORELBINE | N | N | 310024381 | UKALL2011 |
| 310005578 | 310007077 | 1.76 | null | Adjuvant (A) | 2016-09-26 | 2016-10-06 | LENALIDOMIDE | Y | null | 310024381 | METHOTREXATE |
| 310005579 | 310010462 | 1.53 | null | Curative (C) | 2014-05-08 | 2014-05-10 | FEC 100 + DOCETAXEL | N | N | 310024447 | DABRAFENIB |
| 310005580 | 310002596 | 1.74 | 62.1 | Palliative (P) | 2018-11-26 | 2018-12-01 | ICON8B TRIAL | 02 | N | 310024468 | BEVACIZUMAB + CARBO |
| 310005581 | 310002597 | 1.62 | 93.7 | Palliative (P) | 2017-05-08 | 2017-05-10 | Doxorubicin + Ifosfamide | 02 | N | 310024470 | CYTARABINE HD + METHOTREXATE HD |
| 310005582 | 310002598 | null | 59 | null | 2017-01-24 | 2017-01-26 | METHOTREXATE | null | N | 310024492 | CYTARABINE INTRATHECAL |
| 310005583 | 310002599 | null | 74.95 | Palliative (P) | 2018-02-04 | 2018-02-08 | PMitCEBO-R | 02 | N | 310024565 | RCEOP |
| 310005584 | 310002600 | 174.3 | null | Palliative (P) | 2017-07-10 | 2017-07-13 | EW EuroEwing 2012 Arm A VIDE | 02 | null | 310024569 | DABRAFENIB |
| 310005585 | 310002601 | 1.72 | 91.2 | Palliative (P) | 2016-03-30 | 2016-04-03 | Lenalidomide 10mg (Cycle 1 to 25) | null | Y | 310024614 | CARBOPLATIN + RT |
| 310005586 | 310002602 | 1.68 | null | Curative (C) | 2017-11-11 | 2017-11-11 | Doxorubicin + Olaratumab | N | null | 310024675 | CVP |
| 310005587 | 310002603 | 1.86 | 77.9 | Palliative (P) | 2018-04-10 | 2018-04-10 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | Y | 310024693 | P-MIT |
| 310005588 | 310002603 | 1.69 | 88.8 | Palliative (P) | 2017-05-23 | 2017-06-02 | BEP 5 Day | 2 | null | 310024693 | RPACE-BOM |
| 310005589 | 310002604 | 1.75 | 62.4 | null | 2015-09-27 | 2015-10-17 | LENALIDOMIDE | null | N | 310024779 | PAZOPANIB |
| 310005590 | 310002604 | 0 | 100.2 | Palliative (P) | 2017-10-04 | 2017-10-05 | IRINOTECAN + TEMOZOLOMIDE | 2 | N | 310024779 | BENDAMUSTINE + RITUXIMAB |
| 310005591 | 310002604 | 1.57 | 52.6 | Curative (C) | 2014-05-22 | 2014-05-24 | R GCVP | 2 | N | 310024779 | TEMOZOLOMIDE |